Metabolome sequencing reveals that PRMT1 promotes the progression of invasive micropapillary carcinoma of the breast and predicts a poor prognosis
This study identified the metabolic type-related features and intermediate transition morphology of IMPC, and the identification of potential targets of PRMT1 is expected to provide a basis for the precise diagnosis and treatment of breast IMPC.PMID:37301537 | DOI:10.1016/j.ajpath.2023.05.010
Source: The American Journal of Pathology - Category: Pathology Authors: Kailiang Wu Weidong Li Hanjiao Liu Chen Niu Qianqian Shi Jingyue Zhang Guangshen Gao Hui Sun Fangfang Liu Li Fu Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Ductal Carcinoma | Micropapillary Carcinoma | Molecular Biology | Pathology | Study | Transitional Cell Carcinoma